Brigatinib Products | Cleanchem - Brigatinib is a tyrosine kinase inhibitor used in the treatment of non-small cell lung cancer (NSCLC) with ALK mutations. It works by inhibiting the activity of the ALK protein, which is involved in cancer cell growth. It is typically used when other therapies, such as crizotinib, fail.

Brigatinib is a tyrosine kinase inhibitor used in the treatment of non-small cell lung cancer (NSCLC) with ALK mutations. It works by inhibiting the activity of the ALK protein, which is involved in cancer cell growth. It is typically used when other therapies, such as crizotinib, fail.

Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Brigatinib and its associated compounds...

N-Nitroso Brigatinib

Cat. No: CL-BGT-NO-01

CAS No: NA

Mol. F: C28H36ClN8O3P

Mol. Wt: 599.06

Inv. Status: Custom Synthesis

N-Nitroso Brigatinib Impurity 1

Cat. No: CL-BGT-NO-02

CAS No: NA

Mol. F: C29H38ClN8O3P

Mol. Wt: 613.09

Inv. Status: Custom Synthesis

N-Nitroso Brigatinib Impurity 10

Cat. No: CL-BGT-NO-11

CAS No: NA

Mol. F: C29H36ClN10O5P

Mol. Wt: 671.09

Inv. Status: Custom Synthesis

N-Nitroso Brigatinib Impurity 11

Cat. No: CL-BGT-NO-12

CAS No: NA

Mol. F: C30H40ClN8O3P

Mol. Wt: 627.12

Inv. Status: Custom Synthesis

N-Nitroso Brigatinib Impurity 12

Cat. No: CL-BGT-NO-13

CAS No: NA

Mol. F: C30H39ClN9O4P

Mol. Wt: 656.12

Inv. Status: Custom Synthesis

N-Nitroso Brigatinib Impurity 13

Cat. No: CL-BGT-NO-14

CAS No: NA

Mol. F: C20H25Cl2N7O2

Mol. Wt: 466.36

Inv. Status: Custom Synthesis

N-Nitroso Brigatinib Impurity 14

Cat. No: CL-BGT-NO-15

CAS No: NA

Mol. F: C20H24Cl2N8O3

Mol. Wt: 495.36

Inv. Status: Custom Synthesis

N-Nitroso Brigatinib Impurity 15

Cat. No: CL-BGT-NO-16

CAS No: NA

Mol. F: C28H34ClN10O5P

Mol. Wt: 657.06

Inv. Status: Custom Synthesis

N-Nitroso Brigatinib Impurity 16

Cat. No: CL-BGT-NO-17

CAS No: NA

Mol. F: C28H35ClN9O4P

Mol. Wt: 628.06

Inv. Status: Custom Synthesis

N-Nitroso Brigatinib Impurity 17

Cat. No: CL-BGT-NO-18

CAS No: NA

Mol. F: C28H36ClN8O3P

Mol. Wt: 599.06

Inv. Status: Custom Synthesis

N-Nitroso Brigatinib Impurity 2

Cat. No: CL-BGT-NO-03

CAS No: NA

Mol. F: C37H52ClN11O3

Mol. Wt: 734.33

Inv. Status: Custom Synthesis

N-Nitroso Brigatinib Impurity 3

Cat. No: CL-BGT-NO-04

CAS No: NA

Mol. F: C36H49ClN12O4

Mol. Wt: 749.31

Inv. Status: Custom Synthesis

N-Nitroso Brigatinib Impurity 4

Cat. No: CL-BGT-NO-05

CAS No: NA

Mol. F: C36H48ClN13O5

Mol. Wt: 778.3

Inv. Status: Custom Synthesis

N-Nitroso Brigatinib Impurity 5

Cat. No: CL-BGT-NO-06

CAS No: NA

Mol. F: C36H47ClN14O6

Mol. Wt: 807.3

Inv. Status: Custom Synthesis

N-Nitroso Brigatinib Impurity 6

Cat. No: CL-BGT-NO-07

CAS No: NA

Mol. F: C24H27ClN7O5P

Mol. Wt: 559.94

Inv. Status: Custom Synthesis

N-Nitroso Brigatinib Impurity 7

Cat. No: CL-BGT-NO-08

CAS No: NA

Mol. F: C24H28ClN6O4P

Mol. Wt: 530.94

Inv. Status: Custom Synthesis

N-Nitroso Brigatinib Impurity 8

Cat. No: CL-BGT-NO-09

CAS No: NA

Mol. F: C29H38ClN8O3P

Mol. Wt: 613.09

Inv. Status: Custom Synthesis

N-Nitroso Brigatinib Impurity 9

Cat. No: CL-BGT-NO-10

CAS No: NA

Mol. F: C29H37ClN9O4P

Mol. Wt: 642.09

Inv. Status: Custom Synthesis